Mersana Therapeutics
MRSN
$3.46
Share price
2.98%
Change (1 day)
-45.94%
Change (1 year)
Categories
Mersana Therapeutics (MRSN) - P/B ratio
P/B ratio as of May 2024 : 11.1
According to Mersana Therapeutics's latest financial reports the company has a price-to-book ratio of 11.1.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Mersana Therapeutics - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 7.58 | 19.35% |
| 2022-12-31 | 6.35 | 72.86% |
| 2021-12-31 | 3.67 | -54.02% |
| 2020-12-31 | 7.99 | 140.65% |
| 2019-12-31 | 3.32 | -69.19% |
| 2018-12-31 | 10.8 | 101.81% |
| 2017-12-31 | 5.34 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -74.29% | 🇺🇸 USA |